With student health needs on the rise, state officials want to make sure every school has a nurse on hand.
However, tight budgets are making it a challenge. According to the Michigan Association of School Nurses, 600,000 Michigan students manage at least one chronic condition, and 25% take daily medications. Therefore, the presence of school nurses is vital for ensuring the mental and physical health and safety of students.
Today, the American Nurses Foundation (ANF) announced the 2024 recipients of a pioneering, scholarship program developed in partnership with Stryker, a leading global medical technology company.
It’s called the Scholars for Change program and it takes effect on the first day of the ANCC National Magnet Conference® and Pathway to Excellence Conference® held this year in New Orleans, Louisiana on October 30 – November 1. This unique program was created to intentionally engage and support nurse leaders of color to positively influence their organizations with the Magnet Recognition Program and Pathway to Excellence professional standards of practice.
McNeese State University’s nurse practitioner program was ranked as the second best in the state of Louisiana.
The rankings, which are determined by RegisteredNursing.org, are based on factors like completion rates, affordability, institutional reputation, program diversity, and faculty expertise.
Telehealth companies Hims & Hers Health Inc., Noom Inc. and Sesame Inc. have lured individual customers with low-cost versions of popular weight-loss shots like Ozempic and Wegovy. Now, they're going after employers, too, as the medications become an in-demand perk. After Noom began offering a compounded copy of Wegovy for $149 a month, CEO Geoff Cook says he was 'actually a little surprised' by the level of employer interest.
Patients visiting emergency departments for dehydration or nausea are half as likely to receive IV fluids now than they were before Hurricane Helene exacerbated supply shortages. When the storm hit western North Carolina last month, flooding and other damage halted production at Baxter's North Cove facility, which provides about 60% of IV fluids to hospitals across the U.S. The disruptions have led to multiple new shortages.
Data from over 3 million people who had been using Flovent showed a 17.5% increase in asthma-related hospitalization in the three months after Flovent was discontinued, and a 24.1% increase in the following three to six months. ICU admissions for asthma in those previously using Flovent increased 17.4% three months after discontinuation, and 23.1% three to six months after discontinuation. The data included children and adults.